GBS Inc. (NYSE:GBS – Get Free Report)’s share price rose 0.9% during trading on Thursday . The company traded as high as $2.28 and last traded at $2.20. Approximately 52,371 shares changed hands during trading, a decline of 95% from the average daily volume of 955,325 shares. The stock had previously closed at $2.18.
GBS Stock Up 0.9 %
The stock has a market cap of $32.76 million, a PE ratio of -3.93 and a beta of 1.32. The stock has a 50-day moving average of $1.83 and a 200 day moving average of $1.64.
About GBS
GBS Inc operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
Further Reading
- Five stocks we like better than GBS
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Options Trading – Understanding Strike Price
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Should You Invest in Penny Stocks?
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.
